Gerresheimer (ETR:GXI) Stock Falls 1.9% – Should You Sell?

Gerresheimer AG (ETR:GXI)’s share price was down 1.9% during trading on Friday. The stock traded as low as €26.18 and last traded at €26.18. 67,018 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 140,925 shares. The stock had previously closed at €26.68.

Gerresheimer Stock Down 1.9%

The firm has a market cap of $896.32 million, a PE ratio of 7.84, a P/E/G ratio of 0.82 and a beta of 0.48. The company has a debt-to-equity ratio of 147.98, a quick ratio of 0.40 and a current ratio of 0.81. The firm’s 50-day moving average price is €27.36 and its two-hundred day moving average price is €25.07.

About Gerresheimer

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.